# Nosh.bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nosh-bio

- Industry: Biotechnology
- Headquarters: Berlin, Germany
- Website: www.nosh.bio
- Total disclosed funding: $3.5M
- Latest round: Seed (Mar 30, 2023)
- Investors on record: 4

## About

Based in Germany, and founded in 2022 by Tim Fronzek (CEO), Felipe Lino, and Xiangdong Zhao, Nosh.bio GmbH operates as a biotechnology company that specializes in offering functional ingredients derived from microbial biomass. In April 2023, Nosh.bio GmbH raised EUR 3.2 million in seed funding led by Earlybird Venture Capital, with participation from Clear Current Capital, Good Seed Ventures, and Grey Silo Ventures.

Nosh.bio GmbH is a biotechnology firm that seeks to accelerate the transition to sustainable, animal-free diets. To do so, they use original proprietary fermentation and mild downstream processing technologies to generate ingredients with better functionalities and nutritional protein from natural microbial biodiversity. This approach allows the company to provide clients with easy access to ingredients that have both functional and health benefits.

The company plans to use the April 2023 funding to do advanced research and development initiatives, prepare for mass production, and step up commercialization efforts.

## Funding rounds

- Seed, Mar 30, 2023, $3.5M — Earlybird, Clear Current Capital, Good Seed Ventures, Grey Silo Ventures

## Investors

- Earlybird (https://capitalatlas.ai/funds/earlybird) — Seed
- Clear Current Capital (https://capitalatlas.ai/funds/clear-current-capital) — Seed
- Good Seed Ventures (https://capitalatlas.ai/funds/good-seed-ventures) — Seed
- Grey Silo Ventures (https://capitalatlas.ai/funds/grey-silo-ventures) — Seed